151 related articles for article (PubMed ID: 34291800)
1. Visceral Adipose Tissue Volumetrics Inform Odds of Treatment Response and Risk of Subsequent Surgery in IBD Patients Starting Antitumor Necrosis Factor Therapy.
Gu P; Chhabra A; Chittajallu P; Chang C; Mendez D; Gilman A; Fudman DI; Xi Y; Feagins LA
Inflamm Bowel Dis; 2022 May; 28(5):657-666. PubMed ID: 34291800
[TBL] [Abstract][Full Text] [Related]
2. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
3. Visceral Adiposity Independently Predicts Time to Flare in Inflammatory Bowel Disease but Body Mass Index Does Not.
Sehgal P; Su S; Zech J; Nobel Y; Luk L; Economou I; Shen B; Lewis JD; Freedberg DE
Inflamm Bowel Dis; 2024 Apr; 30(4):594-601. PubMed ID: 37307420
[TBL] [Abstract][Full Text] [Related]
4. Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation Study.
Yarur AJ; Bruss A; Moosreiner A; Beniwal-Patel P; Nunez L; Berens B; Colombel JF; Targan SR; Fox C; Melmed GY; Abreu MT; Deepak P
Gastroenterology; 2023 Oct; 165(4):963-975.e5. PubMed ID: 37499955
[TBL] [Abstract][Full Text] [Related]
5. Pre-operative visceral adipose tissue radiodensity is a potentially novel prognostic biomarker for early endoscopic post-operative recurrence in Crohn's disease.
Gu P; Dube S; Gellada N; Choi SY; Win S; Lee YJ; Yang S; Haritunians T; Melmed GY; Vasiliauskas EA; Bonthala N; Syal G; Yarur AJ; Ziring D; Rabizadeh S; Fleshner P; Kallman C; Devkota S; Targan SR; Li D; McGovern DP
World J Gastrointest Surg; 2024 Mar; 16(3):740-750. PubMed ID: 38577075
[TBL] [Abstract][Full Text] [Related]
6. Impact of abdominal visceral adipose tissue on disease outcome in pediatric Crohn's disease.
Uko V; Vortia E; Achkar JP; Karakas P; Fiocchi C; Worley S; Kay MH
Inflamm Bowel Dis; 2014 Dec; 20(12):2286-91. PubMed ID: 25222655
[TBL] [Abstract][Full Text] [Related]
7. Visceral Adipose Tissue Is Associated With Stricturing Crohn's Disease Behavior, Fecal Calprotectin, and Quality of Life.
Bryant RV; Schultz CG; Ooi S; Goess C; Costello SP; Vincent AD; Schoeman S; Lim A; Bartholomeusz FD; Travis SPL; Andrews JM
Inflamm Bowel Dis; 2019 Feb; 25(3):592-600. PubMed ID: 30215805
[TBL] [Abstract][Full Text] [Related]
8. Visceral Adiposity, Genetic Susceptibility, and Risk of Complications Among Individuals with Crohn's Disease.
Van Der Sloot KW; Joshi AD; Bellavance DR; Gilpin KK; Stewart KO; Lochhead P; Garber JJ; Giallourakis C; Yajnik V; Ananthakrishnan AN; Alizadeh BZ; Xavier RJ; Khalili H
Inflamm Bowel Dis; 2017 Jan; 23(1):82-88. PubMed ID: 27893544
[TBL] [Abstract][Full Text] [Related]
9. Patients With Inflammatory Bowel Diseases and Higher Visceral Adipose Tissue Burden May Benefit From Higher Infliximab Concentrations to Achieve Remission.
Yarur AJ; Abreu MT; Deepak P; Beniwal-Patel P; Papamichael K; Vaughn B; Bruss A; Sekhri S; Moosreiner A; Gu P; Kennedy W; Dubinsky M; Cheifetz A; Melmed GY
Am J Gastroenterol; 2023 Nov; 118(11):2005-2013. PubMed ID: 37207314
[TBL] [Abstract][Full Text] [Related]
10. Volumetric visceral fat machine learning phenotype on CT for differential diagnosis of inflammatory bowel disease.
Zhou Z; Xiong Z; Cheng R; Luo Q; Li Y; Xie Q; Xiao P; Hu D; Hu X; Shen Y; Li Z
Eur Radiol; 2023 Mar; 33(3):1862-1872. PubMed ID: 36255487
[TBL] [Abstract][Full Text] [Related]
11. Association of visceral obesity and early colorectal neoplasia.
Choe EK; Kim D; Kim HJ; Park KJ
World J Gastroenterol; 2013 Dec; 19(45):8349-56. PubMed ID: 24363527
[TBL] [Abstract][Full Text] [Related]
12. Visceral abdominal obesity is associated with an increased risk of irritable bowel syndrome.
Lee CG; Lee JK; Kang YS; Shin S; Kim JH; Lim YJ; Koh MS; Lee JH; Kang HW
Am J Gastroenterol; 2015 Feb; 110(2):310-9. PubMed ID: 25583325
[TBL] [Abstract][Full Text] [Related]
13. Association between visceral and subcutaneous adipose depots and incident cardiovascular disease risk factors.
Abraham TM; Pedley A; Massaro JM; Hoffmann U; Fox CS
Circulation; 2015 Oct; 132(17):1639-47. PubMed ID: 26294660
[TBL] [Abstract][Full Text] [Related]
14. The relationship between DXA-based and anthropometric measures of visceral fat and morbidity in women.
Direk K; Cecelja M; Astle W; Chowienczyk P; Spector TD; Falchi M; Andrew T
BMC Cardiovasc Disord; 2013 Apr; 13():25. PubMed ID: 23552273
[TBL] [Abstract][Full Text] [Related]
15. Visceral adipose tissue glucose uptake is linked to prognosis in multiple myeloma patients: An exploratory study.
da Cunha Júnior AD; Silveira MN; Takahashi MES; de Souza EM; Mosci C; Ramos CD; Brambilla SR; Pericole FV; Prado CM; Mendes MCS; Carvalheira JBC
Clin Nutr; 2021 Jun; 40(6):4075-4084. PubMed ID: 33632534
[TBL] [Abstract][Full Text] [Related]
16. Associations Between Obesity and the Effectiveness of Anti-Tumor Necrosis Factor-α Agents in Inflammatory Bowel Disease Patients: A Literature Review and Meta-analysis.
Dai ZH; Xu XT; Ran ZH
Ann Pharmacother; 2020 Aug; 54(8):729-741. PubMed ID: 31955605
[No Abstract] [Full Text] [Related]
17. Effects of visceral adipose tissue on anti-tumour necrosis factor-α in Crohn's disease.
Li K; Gong P; Zhang Y; Liu M; Zhang Z; Yu X; Ye M; Tian L
Therap Adv Gastroenterol; 2023; 16():17562848231171962. PubMed ID: 37168400
[TBL] [Abstract][Full Text] [Related]
18. Impact of abdominal fat distribution, visceral fat, and subcutaneous fat on coronary plaque scores assessed by 320-row computed tomography coronary angiography.
Tanaka T; Kishi S; Ninomiya K; Tomii D; Koseki K; Sato Y; Okuno T; Sato K; Koike H; Yahagi K; Komiyama K; Aoki J; Tanabe K
Atherosclerosis; 2019 Aug; 287():155-161. PubMed ID: 31295672
[TBL] [Abstract][Full Text] [Related]
19. Associations of Abdominal Subcutaneous and Visceral Fat with Insulin Resistance and Secretion Differ Between Men and Women: The Netherlands Epidemiology of Obesity Study.
de Mutsert R; Gast K; Widya R; de Koning E; Jazet I; Lamb H; le Cessie S; de Roos A; Smit J; Rosendaal F; den Heijer M
Metab Syndr Relat Disord; 2018 Feb; 16(1):54-63. PubMed ID: 29338526
[TBL] [Abstract][Full Text] [Related]
20. Early increase of abdominal adiposity in patients with spondyloarthritis receiving anti-tumor necrosis factor-α treatment.
Hmamouchi I; Roux C; Paternotte S; Kolta S; Dougados M; Briot K
J Rheumatol; 2014 Jun; 41(6):1112-7. PubMed ID: 24737911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
